The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Purpose
To investigate the conditional overall survival (OS) of metastatic castration‐resistant prostate cancer (mCRPC) patients receiving docetaxel chemotherapy.
Methods
We used deidentified patient‐level data from the Prostate Cancer DREAM Challenge database and the control arm of the ENTHUSE 14 trial. We identified 2158 chemonaïve mCRPC patients undergoing docetaxel chemotherapy in the five...
Background
Racial and ethnic disparities in prostate cancer (PCa) mortality are partially mediated by inequities in quality of care. Intermediate‐ and high‐risk PCa can be treated with either surgery or radiation, therefore we designed a study to assess the magnitude of race‐based differences in cancer‐specific survival between these two treatment modalities.
Methods
Non‐Hispanic Black (NHB) and...